Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.10.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.213NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.56 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.39.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.91.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
AY.4.14 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.359NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
BN.1.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.66NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.485NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.73NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.112.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Q.8 (Alpha)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.122.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.5.6 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.440NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.23.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.104 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.198NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAFNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BC.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.17.1 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.375NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBHNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.78NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.9.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.82NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.79.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used